Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death

被引:41
作者
Surges, Rainer [1 ]
Shmuely, Sharon [2 ,3 ]
Dietze, Christoph [2 ]
Ryvlin, Philippe [4 ]
Thijs, Roland D. [2 ,3 ,5 ]
机构
[1] Univ Bonn, Med Ctr, Dept Epileptol, Venusberg Campus 1, D-53127 Bonn, Germany
[2] Stichting Epilepsie Instellingen Nederland SEIN, Achterweg 5, NL-2103 SW Heemstede, Netherlands
[3] NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Queen Sq Inst Neurol, Queen Sq, London WC1N 3BG, England
[4] CHU Vaudois, Dept Clin Neurosci, Rue Bugnon 21, CH-1011 Lausanne, Switzerland
[5] Leiden Univ, Med Ctr, Dept Neurol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
关键词
cardiac arrhythmias; coronary artery disease; electrocardiogram; antiseizure medication; antiepileptic drugs; syncope; sudden cardiac death; premature mortality; SUDDEN UNEXPECTED DEATH; T-WAVE ALTERNANS; VAGUS NERVE-STIMULATION; LONG QT SYNDROME; HEART-RATE-VARIABILITY; ICTAL ASYSTOLE; ELECTRICAL INSTABILITY; ANTIEPILEPTIC DRUGS; ATRIAL-FIBRILLATION; POTENTIAL ROLE;
D O I
10.1684/epd.2021.1254
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
People with epilepsy have a three-fold increased risk of dying prematurely, and a significant proportion is due to sudden cardiac death or acute myocardial infarctions. The causes of increased cardiovascular morbidity and mortality in epilepsy are manifold and include acute or remote effects of epileptic seizures, the longstanding epilepsy itself or antiseizure treatments. Seizure-related cardiac arrhythmias are common and comprise bradyarrhythmia and asystole, atrial fibrillation and ventricular tachycardia. The most frequent clinically relevant seizure-related arrhythmia is ictal asystole that may require implantation of a cardiac pacemaker, whereas seizure-related ventricular tachycardias are only rarely reported. Takotsubo cardiomyopathy and myocardial infarction are rare complications and predominantly described in association with tonic-clonic seizures. Epilepsy-related cardiac complications include a disturbed cardiac autonomic nervous system and acquired dysfunction of the heart (recently defined as 'epileptic heart'), probably contributing to the abnormalities of cardiac repolarisation and elevated risk of sudden cardiac death in people with epilepsy. If successful, the use of antiseizure medication prevents seizure-related cardiac arrhythmias and remote cardiac complications. However, enzyme-inducing antiseizure medications have a negative impact on cardiovascular risk factors, which may further be aggravated by weight gain linked to specific antiseizure drugs. Given the severe consequences of cardiac risks, the aim of this educational review is to explain the many facets of cardiac complications and their underlying causes, and to enable the reader to recognize and manage these risks with the goal to mitigate the cardiac risks in people with epilepsy. Features of syncope are explained in detail, as syncope of all origins can be mistaken as epileptic seizures in people with or without epilepsy, and ictal syncope (i.e. seizure-induced syncope) can easily be ignored.
引用
收藏
页码:17 / 39
页数:23
相关论文
共 144 条
  • [1] Increased QT dispersion in epileptic children
    Akalin, F
    Tirtir, A
    Yilmaz, Y
    [J]. ACTA PAEDIATRICA, 2003, 92 (08) : 916 - 920
  • [2] Prevalence and spectrum of electroencephalogram-identified epileptiform activity among patients with long QT syndrome
    Anderson, Jason H.
    Bos, J. Martijn
    Cascino, Gregory D.
    Ackerman, Michael J.
    [J]. HEART RHYTHM, 2014, 11 (01) : 53 - 57
  • [3] Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications
    Auerbach, David S.
    Biton, Yitschak
    Polonsky, Bronislava
    McNitt, Scott
    Gross, Robert A.
    Dirksen, Robert T.
    Moss, Arthur J.
    [J]. TRANSLATIONAL RESEARCH, 2018, 191 : 81 - 92
  • [4] Genetic biomarkers for the risk of seizures in long QT syndrome
    Auerbach, David S.
    McNitt, Scott
    Gross, Robert A.
    Zareba, Wojciech
    Dirksen, Robert T.
    Moss, Arthur J.
    [J]. NEUROLOGY, 2016, 87 (16) : 1660 - 1668
  • [5] New SCN5A mutation in a SUDEP victim with idiopathic epilepsy
    Aurlien, Dag
    Leren, Trond P.
    Tauboll, Erik
    Gjerstad, Leif
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2009, 18 (02): : 158 - 160
  • [6] Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy
    Bagnall, Richard D.
    Crompton, Douglas E.
    Petrovski, Slave
    Lam, Lien
    Cutmore, Carina
    Garry, Sarah I.
    Sadleir, Lynette G.
    Dibbens, Leanne M.
    Cairns, Anita
    Kivity, Sara
    Afawi, Zaid
    Regan, Brigid M.
    Duflou, Johan
    Berkovic, Samuel F.
    Scheffer, Ingrid E.
    Semsarian, Christopher
    [J]. ANNALS OF NEUROLOGY, 2016, 79 (04) : 522 - 534
  • [7] Sudden unexpected death in epilepsy in a patient with a cardiac pacemaker
    Bank, Anna M.
    Dworetzky, Barbara A.
    Lee, Jong Woo
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 61 : 38 - 40
  • [8] Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications
    Bardai, Abdennasser
    Blom, Marieke T.
    van Noord, Charlotte
    Verhamme, Katia M.
    Sturkenboom, Miriam C. J. M.
    Tan, Hanno L.
    [J]. HEART, 2015, 101 (01) : 17 - 22
  • [9] Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population
    Bardai, Abdennasser
    Lamberts, Robert J.
    Blom, Marieke T.
    Spanjaart, Anne M.
    Berdowski, Jocelyn
    van der Staal, Sebastiaan R.
    Brouwer, Henk J.
    Koster, Rudolph W.
    Sander, Josemir W.
    Thijs, Roland D.
    Tan, Hanno L.
    [J]. PLOS ONE, 2012, 7 (08):
  • [10] Epidemiology and pathophysiology of autonomic seizures: a systematic review
    Baumgartner, Christoph
    Koren, Johannes
    Britto-Arias, Martha
    Schmidt, Simone
    Pirker, Susanne
    [J]. CLINICAL AUTONOMIC RESEARCH, 2019, 29 (02) : 137 - 150